Results 91 to 100 of about 4,676,099 (307)

Steps in immunosuppression for renal transplantation [PDF]

open access: yes, 1983
The authors provide a historical survey of the immunosuppressive agents that have been used to prevent allograft rejection.
Hakala, TR, Rosenthal, JT, Starzl, TE
core  

Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes [PDF]

open access: yes, 2006
BACKGROUND. Alemtuzumab (Campath-1H) induction with tacrolimus monotherapy has been shown to provide effective immunosuppression for kidney, liver, lung, and small bowel transplantation.
Abu-Elmagd   +33 more
core   +1 more source

Immunosuppressants in cancer prevention and therapy [PDF]

open access: yesOncoImmunology, 2013
Rapalogs such as rapamycin (sirolimus), everolimus, temserolimus, and deforolimus are indicated for the treatment of some malignancies. Rapamycin is the most effective cancer-preventive agent currently known, at least in mice, dramatically delaying carcinogenesis in both normal and cancer-prone murine strains.
openaire   +3 more sources

Treatment-resistant inflammatory demyelinating pseudotumor with Marburg-like features: A narrative review-based treatment approach

open access: yesJournal of Research in Medical Sciences
Inflammatory demyelinating pseudotumor (IDP) mimics intracranial neoplasms in terms of both clinical presentation and imaging features. IDP with Marburg-like features represents a severe form of inflammatory demyelinating encephalomyelitis, marked by a ...
Mohammad Amin Najafi   +4 more
doaj   +1 more source

Immunosuppression for liver transplantation in HCV-infected patients: Mechanism-based principles [PDF]

open access: yes, 2005
We retrospectively analyzed 42 hepatitis C virus (HCV)-infected patients who underwent cadaveric liver transplantation under two strategies of immunosuppression: (1) daily tacrolimus (TAC) throughout and an initial cycle of high-dose prednisone (PRED ...
Bass, DC   +10 more
core   +1 more source

De novo head and neck cancer after liver transplant with antibody-based immunosuppression induction [PDF]

open access: yes, 2018
Background Powerful antibody-based immunosuppression induction is now used routinely during organ transplantation, and may place patients at even higher risk of post-transplant cancer.
Graham, Ryan C.   +2 more
core   +1 more source

Financial Aspects of the Immunosuppressive Therapy

open access: yesMedical Archives, 2011
In this study the authors have analyzed the costs associated with the immunosuppressive therapy in patients who underwent organ transplantation in two countries: the United States of America and Bosnia and Herzegovina (i.e. the entity Federation B&H).The goal of this paper is to compare and contrast the costs of the immunosuppressive therapy in two ...
Ognjen Ridic   +6 more
openaire   +3 more sources

The role of T-helper/T-suppressor ratio in the adaptive immune response: a dynamical model [PDF]

open access: yes, 2017
Recent experimental studies have suggested the ratio between T-helper and T-suppressor lymphocytes as an index of immunosuppression in HIV, cancer, immunosenescence and inflammatory and auto-immune diseases. However, a quantitative understanding of the impact of this ratio on the immune response has lagged behind data and its validity as a tool for ...
arxiv   +1 more source

Periodontal Indices in Patients with Rheumatoid Arthritis Undergoing Immunosuppressive Therapy [PDF]

open access: yesمجله دانشگاه علوم پزشکی گرگان
Background and Objective: Periodontitis and rheumatoid arthritis are two chronic inflammatory diseases that are interrelated. Given the similarities between these conditions, the medications used by patients with rheumatoid arthritis (RA) may affect ...
Ilnaz Frahoudi   +2 more
doaj  

Successful treatment with tofacitinib for anti-melanoma differentiation-associated gene 5 antibody-positive juvenile dermatomyositis: case reports and review of the literature

open access: yesImmunological Medicine
Although the clinical efficacy of tofacitinib has been reported in adult patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive (Ab+) dermatomyositis, data on its use in refractory juvenile dermatomyositis (JDM) are scarce.
Susumu Yamazaki   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy